AI pharmaceuticals and CRO concepts picked up in the afternoon. Berry Gene went up and down, breaking out of the 6-day 3-day market. Tenomaibo rose more than 10%, and Jinshi Asia Pharmaceutical, Insight Life, Nuochengjianhua, and Shenzhou Cell soared rapidly. According to the news, IsoMorphic Labs, an AI drug development startup, is advancing preliminary negotiations on a new round of financing. The valuation after this round of investment is at least 40 billion US dollars, and the maximum is expected to reach 50 billion US dollars.

Zhitongcaijing · 2d ago
AI pharmaceuticals and CRO concepts picked up in the afternoon. Berry Gene went up and down, breaking out of the 6-day 3-day market. Tenomaibo rose more than 10%, and Jinshi Asia Pharmaceutical, Insight Life, Nuochengjianhua, and Shenzhou Cell soared rapidly. According to the news, IsoMorphic Labs, an AI drug development startup, is advancing preliminary negotiations on a new round of financing. The valuation after this round of investment is at least 40 billion US dollars, and the maximum is expected to reach 50 billion US dollars.